{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T08:28:43Z","timestamp":1787819323728,"version":"build-2784847793"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,9]]},"abstract":"<jats:p>We present the clinicopathologic and immunohistochemical features of 14 endometrial glandular proliferations with conspicuous corded and hyalinized (CH) features comprised entirely or predominantly of endometrial hyperplasia. Endometrial glandular lesions ranged in severity from endometrial hyperplasia with and without cytologic atypia (5\/14 [36%]) to hyperplasia with architectural complexity bordering on well-differentiated endometrioid adenocarcinoma (3\/14 [21%]) to frank corded and hyalinized endometrial carcinoma (\u201cCHEC\u201d) (6\/14 [43%]). In addition to sex cord\u2013like growth and hyalinized stroma, other common histologic features included prominent spindle cells (11\/14 [79%]), keratinizing and\/or morular squamous differentiation (10\/14 [71%]), and osseous metaplasia (6\/14 [43%]). Immunohistochemical characterization revealed aberrant nuclear beta-catenin in all cases (14\/14 [100%]); additionally, all cases demonstrated positive estrogen receptors, intact PTEN, PMS2 and MSH6, and wild-type p53 expression. Patients ranged in age from 24 to 58 (mean 38) years. Of 5 patients with hyperplasia with CH features, 2 experienced complete resolution after progestin therapy and none progressed to adenocarcinoma (mean follow-up 15.6\u00a0mo, range 2 to 64). By contrast, of 2 patients with hyperplasia bordering on CHEC and with available follow-up, both subsequently developed adenocarcinoma, suggesting that even focal increased architectural complexity may predict an elevated risk of malignancy. We conclude that CH morphology is not limited to endometrioid carcinoma and may occur across a spectrum of neoplastic proliferations, including those without sufficient architectural complexity or cytologic atypia to warrant classification as adenocarcinoma. We propose the term \u201ccorded and hyalinized endometrial hyperplasia\u201d to describe this precursor lesion and report favorable outcomes with conservative treatment.<\/jats:p>","DOI":"10.1097\/pas.0000000000002078","type":"journal-article","created":{"date-parts":[[2023,7,26]],"date-time":"2023-07-26T11:00:06Z","timestamp":1690369206000},"page":"1067-1076","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["The Evolving Spectrum of Endometrial Glandular Proliferations With Corded and Hyalinized Features"],"prefix":"10.1097","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8675-916X","authenticated-orcid":false,"given":"Jennifer","family":"Pors","sequence":"first","affiliation":[{"name":"Department of Pathology, Stanford University School of Medicine, Stanford, CA"},{"name":"Department of Pathology, University of British Columbia, Vancouver, BC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julianna J.","family":"Weiel","sequence":"additional","affiliation":[{"name":"Department of Pathology, Stanford University School of Medicine, Stanford, CA"},{"name":"Department of Pathology, Billings Clinic, Billings, MT"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Ryan","sequence":"additional","affiliation":[{"name":"Department of Pathology, Stanford University School of Medicine, Stanford, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teri A.","family":"Longacre","sequence":"additional","affiliation":[{"name":"Department of Pathology, Stanford University School of Medicine, Stanford, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,7,27]]},"reference":[{"key":"R1-20250608","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/01.pas.0000149704.89463.05","article-title":"Endometrioid carcinomas of the uterine corpus with sex cord-like formations, hyalinization, and other unusual morphologic features: a report of 31 cases of a neoplasm that may be confused with carcinosarcoma and other uterine neoplasms","volume":"29","author":"Murray","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"R2-20250608","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/PGP.0000000000000671","article-title":"Corded and hyalinized endometrioid adenocarcinoma (CHEC) of the uterine corpus are characterized by CTNNB1 mutations and can show adverse clinical outcomes","volume":"40","author":"Ladwig","year":"2021","journal-title":"Int J Gynecol Pathol"},{"key":"R3-20250608","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1097\/PAS.0000000000001737","article-title":"Corded and hyalinized and spindled endometrioid endometrial carcinoma: a clinicopathologic and molecular analysis of 9 tumors based on the TCGA classifier","volume":"45","author":"Safdar","year":"2021","journal-title":"Am J Surg Pathol"},{"key":"R4-20250608","first-page":"149","article-title":"Aberrant nuclear beta-catenin expression in the spindle or corded cells in so-called corded and hyalinized endometrioid carcinomas. Another critical role of the unique morphological feature","volume":"24","author":"Wani","year":"2009","journal-title":"Histol Histopathol"},{"key":"R5-20250608","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1097\/00000478-199504000-00001","article-title":"Proposed criteria for the diagnosis of well-differentiated endometrial carcinoma. A diagnostic test for myoinvasion","volume":"19","author":"Longacre","year":"1995","journal-title":"Am J Surg Pathol"},{"key":"R7-20250608","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nature12113","article-title":"Integrated genomic characterization of endometrial carcinoma","volume":"497","author":"Levine","year":"2013","journal-title":"Nature"},{"key":"R8-20250608","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/PGP.0000000000000583","article-title":"Clinicopathologic and immunohistochemical correlates of CTNNB1 mutated endometrial endometrioid carcinoma","volume":"39","author":"Costigan","year":"2020","journal-title":"Int J Gynecol Pathol"},{"key":"R9-20250608","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1038\/s41379-018-0080-0","article-title":"Nuclear \u03b2-catenin localization and mutation of the CTNNB1 gene: a context-dependent association","volume":"31","author":"Kim","year":"2018","journal-title":"Mod Pathol"},{"key":"R10-20250608","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/PGP.0000000000000865","article-title":"Clinicopathologic evaluation of CTNNB1 mutations in high-intermediate risk endometrial endometrioid carcinoma","volume":"42","author":"Haag","year":"2023","journal-title":"Int J Gynecol Pathol"},{"key":"R11-20250608","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1038\/modpathol.2017.15","article-title":"CTNNB1 (beta-catenin) mutation identifies low grade, early stage endometrial cancer patients at increased risk of recurrence","volume":"30","author":"Kurnit","year":"2017","journal-title":"Mod Pathol"},{"key":"R12-20250608","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jnci\/dju245","article-title":"Clinical significance of CTNNB1 mutation and Wnt pathway activation in endometrioid endometrial carcinoma","volume":"106","author":"Liu","year":"2014","journal-title":"J Natl Cancer Inst"},{"key":"R13-20250608","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s00404-021-06385-0","article-title":"Prognostic significance of CTNNB1 mutation in early stage endometrial carcinoma: a systematic review and meta-analysis","volume":"306","author":"Travaglino","year":"2022","journal-title":"Arch Gynecol Obstet"},{"key":"R14-20250608","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.1158\/1078-0432.CCR-15-2878","article-title":"Improved risk assessment by integrating molecular and clinicopathological factors in early-stage endometrial cancer-combined analysis of the PORTEC cohorts","volume":"22","author":"Stelloo","year":"2016","journal-title":"Clin Cancer Res"},{"key":"R15-20250608","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.ygyno.2019.03.100","article-title":"Molecular markers in recurrent stage I, grade 1 endometrioid endometrial cancers","volume":"153","author":"Moroney","year":"2019","journal-title":"Gynecol Oncol"},{"key":"R16-20250608","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cancers13050950","article-title":"ARID1A and CTNNB1\/\u03b2-catenin molecular status affects the clinicopathologic features and prognosis of endometrial carcinoma: implications for an improved surrogate molecular classification","volume":"13","author":"De Leo","year":"2021","journal-title":"Cancers (Basel)"},{"key":"R17-20250608","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1038\/s41416-023-02141-0","article-title":"Prognostic refinement of NSMP high-risk endometrial cancers using oestrogen receptor immunohistochemistry","volume":"128","author":"Vermij","year":"2023","journal-title":"Br J Cancer"},{"key":"R18-20250608","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.humpath.2017.07.003","article-title":"Clonal evolution in paired endometrial intraepithelial neoplasia\/atypical hyperplasia and endometrioid adenocarcinoma","volume":"67","author":"Russo","year":"2017","journal-title":"Hum Pathol"},{"key":"R19-20250608","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/PGP.0000000000000695","article-title":"Nuclear beta-catenin expression in endometrioid intraepithelial neoplasia (atypical hyperplasia) does not predict carcinoma on subsequent hysterectomy","volume":"40","author":"Wright","year":"2021","journal-title":"Int J Gynecol Pathol"},{"key":"R20-20250608","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/path.4224","article-title":"\u03b2-Catenin activation contributes to the pathogenesis of adenomyosis through epithelial-mesenchymal transition","volume":"231","author":"Oh","year":"2013","journal-title":"J Pathol"},{"key":"R21-20250608","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1097\/PAS.0000000000001934","article-title":"Morules but not squamous differentiation are a reliable indicator of CTNNB1 (\u03b2-catenin) mutations in endometrial carcinoma and precancers","volume":"46","author":"Niu","year":"2022","journal-title":"Am J Surg Pathol"},{"key":"R22-20250608","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s00428-021-03060-2","article-title":"Does endometrial morular metaplasia represent odontogenic differentiation","volume":"479","author":"Travaglino","year":"2021","journal-title":"Virchows Arch"},{"key":"R23-20250608","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1097\/PAS.0000000000001810","article-title":"Reliable identification of endometrial precancers through combined Pax2, \u03b2-catenin, and Pten immunohistochemistry","volume":"46","author":"Aguilar","year":"2022","journal-title":"Am J Surg Pathol"},{"key":"R24-20250608","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1097\/01.pas.0000171001.87599.e2","article-title":"Distinct molecular alterations in complex endometrial hyperplasia (CEH) with and without immature squamous metaplasia (squamous morules)","volume":"29","author":"Brachtel","year":"2005","journal-title":"Am J Surg Pathol"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000002078","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,8]],"date-time":"2025-06-08T21:00:37Z","timestamp":1749416437000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000002078"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,27]]},"references-count":23,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000002078","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7,27]]}}}